{"id":{"repo_id":"greece","oai_identifier":"oai:10442/1982"},"canonical_url":"https://search.ndltd.org/etd/greece/oai:10442/1982","repository":{"repo_id":"greece","name":"Greek National Archive of PhD Theses","base_url":"https://phdtheses.ekt.gr/eadd_oai/request"},"display":{"title":"ΜΟΡΦΟΛΟΓΙΚΗ ΜΕΛΕΤΗ ΤΗΣ ΕΞΕΛΙΞΗΣ ΤΟΥ ΜΑΣΤΟΥ ΘΗΛΕΩΝ ΠΟΝΤΙΚΙΩΝ C3H/SY ΜΕΤΑ ΑΠΟ ΠΡΟΦΥΛΑΚΤΙΚΗ ΧΟΡΗΓΗΣΗ ΤΑΜΟΞΙΦΕΝΗΣ ΚΑΙ CV 205502: ΠΑΡΑΤΗΡΗΣΕΙΣ ΣΤΟ ΟΠΤΙΚΟ ΚΑΙ ΗΛΕΚΤΡΟΝΙΚΟ ΜΙΚΡΟΣΚΟΠΙΟ","abstract":"THE WELL KNOWN NON-STEROIDAL \"ANTIESTROGEN\" TAMOXIFEN (TAM) AND CV 205502 (CV),AN EXPERIMENTAL PROLACTIN-RELEASE INHIBITORY SUBSTANCE, WERE ADMINISTERED PROPHYLACTICALLY, SEPARATE AND COMBINED, AS ANTI-PROMOTERS TO FEMALE VIRGIN C3HMICE DURING THE EARLY PERIOD OF PROMOTION IN THE C3H MODEL (THROUGH THE AGE OF 2 TO 5 MONTHS). THIS STUDY WAS PERFORMED IN ORDER TO DEMONSTRATE THE EFFECTS OF THE ABOVE MENTIONED DRUGS ON THE MORPHOLOGY, ULTRASTRUCTURE AND FURTHER DEVELOPMENT OF THE C3H MAMMARY GLAND (UNTIL THE AGE OF 14 MONTHS). TAM ALONE AND THE COMBINED THERAPY OVERALL DELAYED MOUSE MAMMARY GLAND GROWTH, CAUSING THEFOLLOWING MORPHOLOGICAL ALTERATIONS ON THE DEVELOPING PART OF THE GLAND (TERMINAL END BUDS [TEBS], AND SMALL DUCTULES): 1) INHIBITION OF THE SECRETORY DIFFERENTIATION OF THE EPITHELIAL CELLS, BUT PROMOTION OF THEIR MYOEPITHELIAL DIFFERENTIATION. 2) ALTERATIONS IN THE EPITHELIAL BASEMENT MEMBRANE MORPHOLOGY, WHICH BECAME THICKER, DENSER AND WELL ANCHORED TO THE EXTRACELLULAR MATRIX FIBRILS. 3) ENHANCEMENT OF THE SUPPORTING CONNECTIVE TISSUE COLLAGEN PRODUCTION. 4)PROLONGED DEGENERATIVE CHANGES TO THE EPITHELIAL CELLS. (ABSTRACT TRUNCATED)","abstract_html":"THE WELL KNOWN NON-STEROIDAL &quot;ANTIESTROGEN&quot; TAMOXIFEN (TAM) AND CV 205502 (CV),AN EXPERIMENTAL PROLACTIN-RELEASE INHIBITORY SUBSTANCE, WERE ADMINISTERED PROPHYLACTICALLY, SEPARATE AND COMBINED, AS ANTI-PROMOTERS TO FEMALE VIRGIN C3HMICE DURING THE EARLY PERIOD OF PROMOTION IN THE C3H MODEL (THROUGH THE AGE OF 2 TO 5 MONTHS). THIS STUDY WAS PERFORMED IN ORDER TO DEMONSTRATE THE EFFECTS OF THE ABOVE MENTIONED DRUGS ON THE MORPHOLOGY, ULTRASTRUCTURE AND FURTHER DEVELOPMENT OF THE C3H MAMMARY GLAND (UNTIL THE AGE OF 14 MONTHS). TAM ALONE AND THE COMBINED THERAPY OVERALL DELAYED MOUSE MAMMARY GLAND GROWTH, CAUSING THEFOLLOWING MORPHOLOGICAL ALTERATIONS ON THE DEVELOPING PART OF THE GLAND (TERMINAL END BUDS [TEBS], AND SMALL DUCTULES): 1) INHIBITION OF THE SECRETORY DIFFERENTIATION OF THE EPITHELIAL CELLS, BUT PROMOTION OF THEIR MYOEPITHELIAL DIFFERENTIATION. 2) ALTERATIONS IN THE EPITHELIAL BASEMENT MEMBRANE MORPHOLOGY, WHICH BECAME THICKER, DENSER AND WELL ANCHORED TO THE EXTRACELLULAR MATRIX FIBRILS. 3) ENHANCEMENT OF THE SUPPORTING CONNECTIVE TISSUE COLLAGEN PRODUCTION. 4)PROLONGED DEGENERATIVE CHANGES TO THE EPITHELIAL CELLS. (ABSTRACT TRUNCATED)","abstract_has_math":false,"creators":["Kotoula, Vasiliki","Κωτούλα, Βασιλική"],"institution":"Aristotle University Of Thessaloniki (AUTH)","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":1992,"date_issued":"1992","date_published":"1992","updated_at":"2026-11-18T20:21:16Z","subjects":["ΑΝΤΙΟΙΣΤΡΟΓΟΝΙΚΑ ΦΑΡΜΑΚΑ, ΤΑΜΟΞΙΦΕΝΗ","ΑΝΤΙΠΡΟΛΑΚΤΙΝΙΚΑ ΦΑΡΜΑΚΑ, CV 205502","ΚΑΡΚΙΝΟΣ ΜΑΣΤΟΥ, ΠΡΟΦΥΛΑΞΗ, ΠΡΟΛΗΨΗ, ΚΑΡΚΙΝΟΓΕΝΕΣΗ","ΜΑΣΤΟΣ, ΜΟΡΦΟΛΟΓΙΑ, ΕΠΙΘΗΛΙΟ, ΣΤΡΩΜΑ","ΠΟΝΤΙΚΙΑ, C3H","Υπερμικροσκοπική δομή","ANTIESTROGENS, TAMOXIFEN","C3H, MICE","EPITHELIUM, STROMA","MAMMARY, GLAND, CARCINOGENESIS, TUMORS, PREVENTION, PROPHYLAXIS","MORPHOLOGY, ULTRASTRUCTURE","PROLACTIN LOWERING DRUGS, CV 205502","Ιατρική και Επιστήμες Υγείας","Βασική Ιατρική","Medical and Health Sciences","Basic Medicine"],"languages":["gre"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/1982"],"render_values":[{"text":"10.12681/eadd/1982","href":"https://doi.org/10.12681/eadd/1982","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/10442/hedi/1982","outbound_label":"Handle","outbound_source":"dc:identifier","record_url":"http://hdl.handle.net/10442/hedi/1982","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://phdtheses.ekt.gr/eadd_oai/request?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3A10442%2F1982","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Kotoula, Vasiliki","Κωτούλα, Βασιλική"]},{"key":"dc:creator.fathername","label":"Dc Creator Fathername","values":["Alexandros"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["1992"]},{"key":"dc:publisher","label":"Institution","values":["Aristotle University Of Thessaloniki (AUTH)","Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)"]},{"key":"dc:type","label":"Dc Type","values":["PhD Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["ΑΝΤΙΟΙΣΤΡΟΓΟΝΙΚΑ ΦΑΡΜΑΚΑ, ΤΑΜΟΞΙΦΕΝΗ","ΑΝΤΙΠΡΟΛΑΚΤΙΝΙΚΑ ΦΑΡΜΑΚΑ, CV 205502","ΚΑΡΚΙΝΟΣ ΜΑΣΤΟΥ, ΠΡΟΦΥΛΑΞΗ, ΠΡΟΛΗΨΗ, ΚΑΡΚΙΝΟΓΕΝΕΣΗ","ΜΑΣΤΟΣ, ΜΟΡΦΟΛΟΓΙΑ, ΕΠΙΘΗΛΙΟ, ΣΤΡΩΜΑ","ΠΟΝΤΙΚΙΑ, C3H","Υπερμικροσκοπική δομή","ANTIESTROGENS, TAMOXIFEN","C3H, MICE","EPITHELIUM, STROMA","MAMMARY, GLAND, CARCINOGENESIS, TUMORS, PREVENTION, PROPHYLAXIS","MORPHOLOGY, ULTRASTRUCTURE","PROLACTIN LOWERING DRUGS, CV 205502","Ιατρική και Επιστήμες Υγείας","Βασική Ιατρική","Medical and Health Sciences","Basic Medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["gre"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/1982","http://hdl.handle.net/10442/hedi/1982"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["THE WELL KNOWN NON-STEROIDAL \"ANTIESTROGEN\" TAMOXIFEN (TAM) AND CV 205502 (CV),AN EXPERIMENTAL PROLACTIN-RELEASE INHIBITORY SUBSTANCE, WERE ADMINISTERED PROPHYLACTICALLY, SEPARATE AND COMBINED, AS ANTI-PROMOTERS TO FEMALE VIRGIN C3HMICE DURING THE EARLY PERIOD OF PROMOTION IN THE C3H MODEL (THROUGH THE AGE OF 2 TO 5 MONTHS). THIS STUDY WAS PERFORMED IN ORDER TO DEMONSTRATE THE EFFECTS OF THE ABOVE MENTIONED DRUGS ON THE MORPHOLOGY, ULTRASTRUCTURE AND FURTHER DEVELOPMENT OF THE C3H MAMMARY GLAND (UNTIL THE AGE OF 14 MONTHS). TAM ALONE AND THE COMBINED THERAPY OVERALL DELAYED MOUSE MAMMARY GLAND GROWTH, CAUSING THEFOLLOWING MORPHOLOGICAL ALTERATIONS ON THE DEVELOPING PART OF THE GLAND (TERMINAL END BUDS [TEBS], AND SMALL DUCTULES): 1) INHIBITION OF THE SECRETORY DIFFERENTIATION OF THE EPITHELIAL CELLS, BUT PROMOTION OF THEIR MYOEPITHELIAL DIFFERENTIATION. 2) ALTERATIONS IN THE EPITHELIAL BASEMENT MEMBRANE MORPHOLOGY, WHICH BECAME THICKER, DENSER AND WELL ANCHORED TO THE EXTRACELLULAR MATRIX FIBRILS. 3) ENHANCEMENT OF THE SUPPORTING CONNECTIVE TISSUE COLLAGEN PRODUCTION. 4)PROLONGED DEGENERATIVE CHANGES TO THE EPITHELIAL CELLS. (ABSTRACT TRUNCATED)","ΜΕΛΕΤΗΘΗΚΕ Η ΕΠΙΔΡΑΣΗ ΤΗΣ ΜΗ ΣΤΕΡΟΕΙΔΙΚΗΣ ΑΝΤΙΟΙΣΤΡΟΓΟΝΙΚΗΣ ΤΑΜΟΞΙΦΕΝΗΣ (ΤΑΜ) ΚΑΙ ΤΟΥ ΠΕΙΡΑΜΑΤΙΚΟΥ ΑΝΤΙΠΡΟΛΑΚΤΙΝΙΚΟΥ ΣΚΕΥΑΣΜΑΤΟΣ CV 205502 (CV) ΣΤΗ ΜΟΡΦΟΛΟΓΙΑ ΚΑΙ ΤΗΝ ΕΞΕΛΙΞΗ ΤΟΥ ΜΑΣΤΟΥ ΘΗΛΕΩΝ ΠΑΡΘΕΝΩΝ ΠΟΝΤΙΚΙΩΝ ΤΗΣ ΚΑΡΚΙΝΙΚΗΣ ΦΥΛΗΣ C3H/SY. ΤΑ ΦΑΡΜΑΚΑ ΧΟΡΗΓΗΘΗΚΑΝ, ΜΕΜΟΝΩΜΕΝΑ Η ΣΕ ΣΥΝΔΥΑΣΜΟ, ΚΑΤΑ ΤΗΝ ΚΥΡΙΑ ΠΕΡΙΟΔΟ ΠΡΟΑΓΩΓΗΣ ΤΗΣ ΚΑΡΚΙΝΟΓΕΝΕΣΗΣ ΤΟΥ ΜΑΣΤΟΥ ΣΤΟ ΕΝ ΛΟΓΩ ΣΥΣΤΗΜΑ ΣΕ ΠΕΙΡΑΜΑΤΟΖΩΑ ΗΛΙΚΙΑΣ 3-5 ΜΗΝΩΝ, ΤΑ ΟΠΟΙΑ ΠΑΡΑΚΟΛΟΥΘΗΘΗΚΑΝ ΜΕΧΡΙ ΤΗΝ ΗΛΙΚΙΑ ΤΩΝ 14 ΜΗΝΩΝ.Η ΤΑΜ ΚΑΙ Ο ΣΥΝΔΥΑΣΜΟΣ ΤΗΣ ΜΕ ΤΟ CV ΑΝΑΣΤΕΛΛΕΙ ΤΗΝ ΑΥΞΗΣΗ ΤΟΥ ΜΑΣΤΟΥ ΤΩΝ ΠΟΝΤΙΚΙΩΝ ΕΠΙΦΕΡΟΝΤΑΣ ΜΟΡΦΟΛΟΓΙΚΕΣ ΑΛΛΟΙΩΣΕΙΣ ΣΤΟ ΑΝΑΠΤΥΣΣΟΜΕΝΟ ΤΜΗΜΑ ΤΟΥ ΕΠΙΘΗΛΙΑΚΟΥ ΣΤΟΙΧΕΙΟΥ ΤΟΥ ΜΑΣΤΟΥ ΤΩΝ ΠΟΝΤΙΚΙΩΝ (ΤΕΒ, ΜΙΚΡΟΙ ΠΟΡΟΙ), ΟΙ ΚΥΡΙΩΤΕΡΕΣ ΑΠΟΤΙΣ ΟΠΟΙΕΣ ΕΙΝΑΙ ΟΙ ΕΞΗΣ: 1) ΕΠΙΤΑΣΗ ΤΗΣ ΜΥΟΕΠΙΘΗΛΙΑΚΗΣ ΔΙΑΦΟΡΟΠΟΙΗΣΗΣ ΤΩΝ ΕΠΙΘΗΛΙΑΚΩΝ ΚΥΤΤΑΡΩΝ. 2) ΜΕΙΩΣΗ ΤΩΝ ΕΚΚΡΙΤΙΚΩΝ ΧΑΡΑΚΤΗΡΩΝ ΚΑΙ ΠΡΟΟΔΕΥΤΙΚΗ ΥΠΟΣΤΡΟΦΗ ΤΩΝ ΕΠΙΘΗΛΙΑΚΩΝ ΚΥΤΤΑΡΩΝ. 3) ΠΑΧΥΝΣΗ ΚΑΙ ΠΥΚΝΩΣΗ ΤΗΣ ΕΠΙΘΗΛΙΑΚΗΣ ΒΑΣΙΚΗΣ ΜΕΜΒΡΑΝΗΣ. 4) ΑΥΞΗΣΗ ΤΟΥ ΚΟΛΛΑΓΟΝΟΥ ΣΤΡΩΜΑΤΟΣ ΓΥΡΩ ΑΠΟ ΤΑ ΙΣΤΟΛΟΓΙΚΑ ΣΤΟΙΧΕΙΑ ΠΟΥ ΑΝΑΦΕΡΘΗΚΑΝ, ΚΑΘΩΣ ΚΑΙ ΑΥΞΗΜΕΝΗ ΣΥΝΔΕΣΗ ΤΟΥΣ ΜΕ ΤΗΝ ΕΠΙΘΗΛΙΑΚΗ ΒΑΣΙΚΗ ΜΕΜΒΡΑΝΗ. ΟΙ ΑΛΛΟΙΩΣΕΙΣ ΑΥΤΕΣ ΕΓΚΑΘΙΣΤΑΝΤΑΙ ΠΡΟΟΔΕΥΤΙΚΑ ΚΑΤΑ ΤΗ ΔΙΑΡΚΕΙΑ ΤΗΣ ΧΟΡΗΓΗΣΗΣ ΤΗΣ ΤΑΜ ΚΑΙ ΤΟΥ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΣΥΝΔΥΑΣΜΟΥ (ΣΥΝΤΟΜΟΤΕΡΑ ΣΤΗ ΔΕΥΤΕΡΗ ΠΕΡΙΠΤΩΣΗ), ΔΙΑΠΙΣΤΩΝΟΝΤΑΙ ΔΕ ΚΑΙ ΜΕΤΑ ΤΟ ΤΕΛΟΣ ΤΗΣ ΘΕΡΑΠΕΙΑΣ (ΓΙΑ 1 ΚΑΙ 3 ΜΗΝΕΣ ΑΝΤΙΣΤΟΙΧΑ). (ΠΕΡΙΚΟΠΗ ΠΕΡΙΛΗΨΗΣ)"]},{"key":"dc:title","label":"Title","values":["ΜΟΡΦΟΛΟΓΙΚΗ ΜΕΛΕΤΗ ΤΗΣ ΕΞΕΛΙΞΗΣ ΤΟΥ ΜΑΣΤΟΥ ΘΗΛΕΩΝ ΠΟΝΤΙΚΙΩΝ C3H/SY ΜΕΤΑ ΑΠΟ ΠΡΟΦΥΛΑΚΤΙΚΗ ΧΟΡΗΓΗΣΗ ΤΑΜΟΞΙΦΕΝΗΣ ΚΑΙ CV 205502: ΠΑΡΑΤΗΡΗΣΕΙΣ ΣΤΟ ΟΠΤΙΚΟ ΚΑΙ ΗΛΕΚΤΡΟΝΙΚΟ ΜΙΚΡΟΣΚΟΠΙΟ","A STUDY ON THE MORPHOLOGY AND EVOLUTION OF THE MAMMARY GLAND AFTER PROPHYLACTICADMINISTRATION OF TAMOXIFEN AND CV 205502 TO FEMALE C3H/SY MICE: LIGHT AND ELECTRON MICROSCOPIC OBSERVATIONS"]}]}],"canonical_facts":{"dc:creator":["Kotoula, Vasiliki","Κωτούλα, Βασιλική"],"dc:creator.fathername":["Alexandros"],"dc:date":["1992"],"dc:description":["THE WELL KNOWN NON-STEROIDAL \"ANTIESTROGEN\" TAMOXIFEN (TAM) AND CV 205502 (CV),AN EXPERIMENTAL PROLACTIN-RELEASE INHIBITORY SUBSTANCE, WERE ADMINISTERED PROPHYLACTICALLY, SEPARATE AND COMBINED, AS ANTI-PROMOTERS TO FEMALE VIRGIN C3HMICE DURING THE EARLY PERIOD OF PROMOTION IN THE C3H MODEL (THROUGH THE AGE OF 2 TO 5 MONTHS). THIS STUDY WAS PERFORMED IN ORDER TO DEMONSTRATE THE EFFECTS OF THE ABOVE MENTIONED DRUGS ON THE MORPHOLOGY, ULTRASTRUCTURE AND FURTHER DEVELOPMENT OF THE C3H MAMMARY GLAND (UNTIL THE AGE OF 14 MONTHS). TAM ALONE AND THE COMBINED THERAPY OVERALL DELAYED MOUSE MAMMARY GLAND GROWTH, CAUSING THEFOLLOWING MORPHOLOGICAL ALTERATIONS ON THE DEVELOPING PART OF THE GLAND (TERMINAL END BUDS [TEBS], AND SMALL DUCTULES): 1) INHIBITION OF THE SECRETORY DIFFERENTIATION OF THE EPITHELIAL CELLS, BUT PROMOTION OF THEIR MYOEPITHELIAL DIFFERENTIATION. 2) ALTERATIONS IN THE EPITHELIAL BASEMENT MEMBRANE MORPHOLOGY, WHICH BECAME THICKER, DENSER AND WELL ANCHORED TO THE EXTRACELLULAR MATRIX FIBRILS. 3) ENHANCEMENT OF THE SUPPORTING CONNECTIVE TISSUE COLLAGEN PRODUCTION. 4)PROLONGED DEGENERATIVE CHANGES TO THE EPITHELIAL CELLS. (ABSTRACT TRUNCATED)","ΜΕΛΕΤΗΘΗΚΕ Η ΕΠΙΔΡΑΣΗ ΤΗΣ ΜΗ ΣΤΕΡΟΕΙΔΙΚΗΣ ΑΝΤΙΟΙΣΤΡΟΓΟΝΙΚΗΣ ΤΑΜΟΞΙΦΕΝΗΣ (ΤΑΜ) ΚΑΙ ΤΟΥ ΠΕΙΡΑΜΑΤΙΚΟΥ ΑΝΤΙΠΡΟΛΑΚΤΙΝΙΚΟΥ ΣΚΕΥΑΣΜΑΤΟΣ CV 205502 (CV) ΣΤΗ ΜΟΡΦΟΛΟΓΙΑ ΚΑΙ ΤΗΝ ΕΞΕΛΙΞΗ ΤΟΥ ΜΑΣΤΟΥ ΘΗΛΕΩΝ ΠΑΡΘΕΝΩΝ ΠΟΝΤΙΚΙΩΝ ΤΗΣ ΚΑΡΚΙΝΙΚΗΣ ΦΥΛΗΣ C3H/SY. ΤΑ ΦΑΡΜΑΚΑ ΧΟΡΗΓΗΘΗΚΑΝ, ΜΕΜΟΝΩΜΕΝΑ Η ΣΕ ΣΥΝΔΥΑΣΜΟ, ΚΑΤΑ ΤΗΝ ΚΥΡΙΑ ΠΕΡΙΟΔΟ ΠΡΟΑΓΩΓΗΣ ΤΗΣ ΚΑΡΚΙΝΟΓΕΝΕΣΗΣ ΤΟΥ ΜΑΣΤΟΥ ΣΤΟ ΕΝ ΛΟΓΩ ΣΥΣΤΗΜΑ ΣΕ ΠΕΙΡΑΜΑΤΟΖΩΑ ΗΛΙΚΙΑΣ 3-5 ΜΗΝΩΝ, ΤΑ ΟΠΟΙΑ ΠΑΡΑΚΟΛΟΥΘΗΘΗΚΑΝ ΜΕΧΡΙ ΤΗΝ ΗΛΙΚΙΑ ΤΩΝ 14 ΜΗΝΩΝ.Η ΤΑΜ ΚΑΙ Ο ΣΥΝΔΥΑΣΜΟΣ ΤΗΣ ΜΕ ΤΟ CV ΑΝΑΣΤΕΛΛΕΙ ΤΗΝ ΑΥΞΗΣΗ ΤΟΥ ΜΑΣΤΟΥ ΤΩΝ ΠΟΝΤΙΚΙΩΝ ΕΠΙΦΕΡΟΝΤΑΣ ΜΟΡΦΟΛΟΓΙΚΕΣ ΑΛΛΟΙΩΣΕΙΣ ΣΤΟ ΑΝΑΠΤΥΣΣΟΜΕΝΟ ΤΜΗΜΑ ΤΟΥ ΕΠΙΘΗΛΙΑΚΟΥ ΣΤΟΙΧΕΙΟΥ ΤΟΥ ΜΑΣΤΟΥ ΤΩΝ ΠΟΝΤΙΚΙΩΝ (ΤΕΒ, ΜΙΚΡΟΙ ΠΟΡΟΙ), ΟΙ ΚΥΡΙΩΤΕΡΕΣ ΑΠΟΤΙΣ ΟΠΟΙΕΣ ΕΙΝΑΙ ΟΙ ΕΞΗΣ: 1) ΕΠΙΤΑΣΗ ΤΗΣ ΜΥΟΕΠΙΘΗΛΙΑΚΗΣ ΔΙΑΦΟΡΟΠΟΙΗΣΗΣ ΤΩΝ ΕΠΙΘΗΛΙΑΚΩΝ ΚΥΤΤΑΡΩΝ. 2) ΜΕΙΩΣΗ ΤΩΝ ΕΚΚΡΙΤΙΚΩΝ ΧΑΡΑΚΤΗΡΩΝ ΚΑΙ ΠΡΟΟΔΕΥΤΙΚΗ ΥΠΟΣΤΡΟΦΗ ΤΩΝ ΕΠΙΘΗΛΙΑΚΩΝ ΚΥΤΤΑΡΩΝ. 3) ΠΑΧΥΝΣΗ ΚΑΙ ΠΥΚΝΩΣΗ ΤΗΣ ΕΠΙΘΗΛΙΑΚΗΣ ΒΑΣΙΚΗΣ ΜΕΜΒΡΑΝΗΣ. 4) ΑΥΞΗΣΗ ΤΟΥ ΚΟΛΛΑΓΟΝΟΥ ΣΤΡΩΜΑΤΟΣ ΓΥΡΩ ΑΠΟ ΤΑ ΙΣΤΟΛΟΓΙΚΑ ΣΤΟΙΧΕΙΑ ΠΟΥ ΑΝΑΦΕΡΘΗΚΑΝ, ΚΑΘΩΣ ΚΑΙ ΑΥΞΗΜΕΝΗ ΣΥΝΔΕΣΗ ΤΟΥΣ ΜΕ ΤΗΝ ΕΠΙΘΗΛΙΑΚΗ ΒΑΣΙΚΗ ΜΕΜΒΡΑΝΗ. ΟΙ ΑΛΛΟΙΩΣΕΙΣ ΑΥΤΕΣ ΕΓΚΑΘΙΣΤΑΝΤΑΙ ΠΡΟΟΔΕΥΤΙΚΑ ΚΑΤΑ ΤΗ ΔΙΑΡΚΕΙΑ ΤΗΣ ΧΟΡΗΓΗΣΗΣ ΤΗΣ ΤΑΜ ΚΑΙ ΤΟΥ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΣΥΝΔΥΑΣΜΟΥ (ΣΥΝΤΟΜΟΤΕΡΑ ΣΤΗ ΔΕΥΤΕΡΗ ΠΕΡΙΠΤΩΣΗ), ΔΙΑΠΙΣΤΩΝΟΝΤΑΙ ΔΕ ΚΑΙ ΜΕΤΑ ΤΟ ΤΕΛΟΣ ΤΗΣ ΘΕΡΑΠΕΙΑΣ (ΓΙΑ 1 ΚΑΙ 3 ΜΗΝΕΣ ΑΝΤΙΣΤΟΙΧΑ). (ΠΕΡΙΚΟΠΗ ΠΕΡΙΛΗΨΗΣ)"],"dc:identifier":["10.12681/eadd/1982","http://hdl.handle.net/10442/hedi/1982"],"dc:language":["gre"],"dc:publisher":["Aristotle University Of Thessaloniki (AUTH)","Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)"],"dc:subject":["ΑΝΤΙΟΙΣΤΡΟΓΟΝΙΚΑ ΦΑΡΜΑΚΑ, ΤΑΜΟΞΙΦΕΝΗ","ΑΝΤΙΠΡΟΛΑΚΤΙΝΙΚΑ ΦΑΡΜΑΚΑ, CV 205502","ΚΑΡΚΙΝΟΣ ΜΑΣΤΟΥ, ΠΡΟΦΥΛΑΞΗ, ΠΡΟΛΗΨΗ, ΚΑΡΚΙΝΟΓΕΝΕΣΗ","ΜΑΣΤΟΣ, ΜΟΡΦΟΛΟΓΙΑ, ΕΠΙΘΗΛΙΟ, ΣΤΡΩΜΑ","ΠΟΝΤΙΚΙΑ, C3H","Υπερμικροσκοπική δομή","ANTIESTROGENS, TAMOXIFEN","C3H, MICE","EPITHELIUM, STROMA","MAMMARY, GLAND, CARCINOGENESIS, TUMORS, PREVENTION, PROPHYLAXIS","MORPHOLOGY, ULTRASTRUCTURE","PROLACTIN LOWERING DRUGS, CV 205502","Ιατρική και Επιστήμες Υγείας","Βασική Ιατρική","Medical and Health Sciences","Basic Medicine"],"dc:title":["ΜΟΡΦΟΛΟΓΙΚΗ ΜΕΛΕΤΗ ΤΗΣ ΕΞΕΛΙΞΗΣ ΤΟΥ ΜΑΣΤΟΥ ΘΗΛΕΩΝ ΠΟΝΤΙΚΙΩΝ C3H/SY ΜΕΤΑ ΑΠΟ ΠΡΟΦΥΛΑΚΤΙΚΗ ΧΟΡΗΓΗΣΗ ΤΑΜΟΞΙΦΕΝΗΣ ΚΑΙ CV 205502: ΠΑΡΑΤΗΡΗΣΕΙΣ ΣΤΟ ΟΠΤΙΚΟ ΚΑΙ ΗΛΕΚΤΡΟΝΙΚΟ ΜΙΚΡΟΣΚΟΠΙΟ","A STUDY ON THE MORPHOLOGY AND EVOLUTION OF THE MAMMARY GLAND AFTER PROPHYLACTICADMINISTRATION OF TAMOXIFEN AND CV 205502 TO FEMALE C3H/SY MICE: LIGHT AND ELECTRON MICROSCOPIC OBSERVATIONS"],"dc:type":["PhD Thesis"]},"updated_at":"2026-11-18T20:21:16Z"}